Neuropsychiatrist Adarsh K. Gupta, MD has been named a 2026 Castle Connolly Top Doctor, marking the 15th consecutive year he has received this prestigious designation. This recognition matters because only 7 percent of the nation's licensed physicians are selected annually as Castle Connolly Top Doctors for their specialties in their regions, indicating exceptional peer recognition and clinical excellence in a highly competitive field.
Dr. Gupta practices at Sleep, TMS & Wellness Psychiatry, where he provides what he describes as 'precision psychiatry' and neuroscience-driven care. As Medical Director, he oversees a clinical environment integrating neuropsychiatric diagnostics with advanced neuromodulation and sleep medicine to address high-acuity psychiatric needs. His board certifications in Psychiatry, Neuropsychiatry, Sleep Medicine, and Mind-Body Medicine reflect the comprehensive approach that distinguishes his practice.
The significance of this recognition extends beyond individual achievement to highlight evolving approaches in mental health treatment. Dr. Gupta evaluates and treats a wide range of primary conditions with particular focus on treatment-resistant depression, generalized anxiety disorder, and obsessive-compulsive disorder. He also specializes in managing complex sleep-wake disorders and neurobehavioral conditions that have not responded to traditional pharmacological interventions.
What makes Dr. Gupta's work particularly important is his utilization of advanced procedures and diagnostic tools tailored to individual biological profiles. These include Transcranial Magnetic Stimulation (TMS), ketamine-assisted treatment, functional near-infrared spectroscopy (fNIRS) brain blood flow assessment, quantitative electroencephalogram (QEEG) brain wave analysis, genetic testing for psychotropic optimization, comprehensive cognitive assessments, diagnostic sleep studies, and facial and speech analysis for monitoring emotional states. The practice features integrated diagnostic capabilities including an on-site laboratory for brain wave analysis and cognitive testing.
Dr. Gupta is deeply committed to advancing precision psychiatric care and actively involved in clinical research focused on optimizing treatment outcomes of TMS therapy in patients with major depressive and anxiety disorders using multimodal neurodiagnostic measures. His medical training includes a Bachelor of Medicine & Surgery from Maulana Azad Medical College, University of Delhi, a Diploma in Dermatology & Venereology from the University of Delhi, a medical internship at Saint Vincent Hospital, and residency in psychiatry at New York University Medical Center.
His specialized training includes three fellowships: Consultation-Liaison Psychiatry at Long Island Jewish Medical Center, Brain Imaging at Mount Sinai School of Medicine, and Neuropsychiatry at Beth Israel Deaconess Medical Center, Harvard Medical School. Dr. Gupta has held significant academic roles, serving for 14 years as an Attending Consultation-Liaison Psychiatrist at Long Island Jewish Medical Center where he trained medical students, residents, and fellows. He holds academic privileges at both Long Island Jewish Medical Center and North Shore University Hospital and has completed specialized training in artificial intelligence implementation in healthcare at Harvard Medical School.
The Castle Connolly selection process adds credibility to this recognition, as Top Doctors are nominated by peer physicians and selected by the physician-led Castle Connolly research team based on rigorous criteria including medical education, training, hospital appointments, and disciplinary histories. Castle Connolly publishes its Top Doctors list at https://castleconnolly.com and in various print and online partner publications. Importantly, doctors cannot pay to be selected, ensuring the recognition reflects genuine professional achievement.
This ongoing recognition matters because it validates innovative approaches to mental health treatment that move beyond traditional models. For patients with treatment-resistant conditions, Dr. Gupta's work represents potential breakthroughs in care. For the psychiatric field, his integration of advanced diagnostics and neuromodulation techniques points toward more personalized, effective treatment paradigms. The 15-year consistency of this recognition suggests sustained excellence and ongoing contributions to advancing psychiatric care through both clinical practice and research.
